May 03, 2018 8:30am EDT DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease
Apr 05, 2018 7:15am EDT DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
Apr 04, 2018 4:00pm EDT DiaMedica to Present at the MicroCap Conference on April 10th in New York City at the Essex House
Feb 22, 2018 7:00am EST DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
